<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-PE17CQKS</identifier><date>2001</date><creator>Tannock, Ian</creator><relation>documents/doc/P/URN_NBN_SI_doc-PE17CQKS_001.pdf</relation><relation>documents/doc/P/URN_NBN_SI_doc-PE17CQKS_001.txt</relation><format format_type="issue">2</format><format format_type="volume">5</format><format format_type="type">article</format><format format_type="extent">str. 52-53</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">14309081</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-PE17CQKS</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Medical oncology</subject><subject language_type_id="slv">Medicinska onkologija</subject><subject language_type_id="eng">Trends</subject><title>Celostni onkološki center</title><title>pismo prof. dr. Iana Tannocka z Univerze v Torontu</title></Record>